Clinical Trials
Eli Lilly Reveals Promising Phase 3 Results for Lebrikizumab in Patients with Skin of Color
Eli Lilly and Company (NYSE: LLY) announced results from a first-of-its-kind study of lebrikizumab specifically designed for people with skin of color...
March 11, 2024 | News
TransThera Launches Global Phase 3 Trial for Cholangiocarcinoma in EU, Receives Orphan Drug Status for Tinengotinib from EMA
TransThera, a clinical-stage biopharmaceutical company dedicated to innovating differentiated drugs globally, today announced that the randomized, controll...
March 11, 2024 | News
First Patient Treated in Phase 2 GvHD Trial
Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, c...
March 06, 2024 | News
Caliway's CBL-514 Gains FDA Orphan Drug and Fast Track Designations for Dercum's Disease Treatment
Caliway Biopharmaceuticals (Caliway) announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to CBL-514 for Dercum...
March 05, 2024 | News
SN Bioscience's SNB-101 Granted FDA Orphan Drug Designation for Pancreatic Cancer Treatment
SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on Feb 27 that the US FDA had granted an orphan drug designation for pancreatic cance...
March 01, 2024 | News
Innovent Begins Phase 1 Trial of IBI3002 in Australia
This FIH study (NCT06213844) is a randomized, double-blind, placebo-controlled, single ascending dose (SAD) study to evaluate the safety, tolerabil...
March 01, 2024 | News
Medidata and Sanofi Boost Trial Efficiency with Expanded Patient-Centric Collaboration
Medidata, a Dassault Systèmes subsidiary and a leading provider of clinical trial solutions for the life sciences industry, today announced a ...
February 29, 2024 | News
Teva Partners with Jiangsu Nhwa to Enhance AUSTEDO® Access in China
“Nhwa has deep neuro-psychiatry expertise and capabilities, from research and development to commercialization,” commented Theodor Wee,...
February 28, 2024 | News
Neomorph, Novo Nordisk Partner on Molecular Glue Degraders for Diseases
Collaboration leverages Neomorph's leading molecular glue discovery platform and Novo Nordisk's extensive expertise in cardiometabolic and rare diseases ...
March 27, 2024 | News
Everest Medicines, Kezar Get China NMPA Nod for Lupus Nephritis Trial
Everest Medicines (HKEX 1952.HK) and Kezar Life Sciences, Inc. (Nasdaq: KZR) announced that the Center for Drug Evaluation (CDE) of China's Natio...
February 27, 2024 | News
Oscotec/ ADEL Launch First Human Trial for Novel Alzheimer's Treatment ADEL-Y01
In a significant stride towards Alzheimer's disease (AD) treatment, Oscotec Inc. in collaboration with ADEL Inc., has announced the initiation of f...
February 26, 2024 | News
Immunofoco Achieves Historic Dual IND Approval for Groundbreaking EpCAM CAR-T Therapy
EpCAM, known for its presence in circulating tumor cells (CTCs) and high expression in primary and metastatic lesions of gastrointestinal tumors, r...
February 26, 2024 | News
Aptamer and Neuro-Bio enter the second phase of Alzheimer’s test development
This latest phase involves development of an additional Optimer binder against the innovative Neuro-Bio target implicated in Alzheimer’s disease, wit...
February 23, 2024 | News
Mabwell's Novel ADC 7MW3711 for Advanced Malignant Solid Tumors Receives FDA Clinical Trial Approval
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its clinical trial application of B7-H3 targe...
February 21, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
